Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/17/2010US20100150872 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2
06/17/2010US20100150869 Use of tellurium compounds for treatment of basal cell carcinoma and/or actinic keratosis
06/17/2010US20100150868 Methods of Individually Optimizing Treatment for an Inflammation Associated Disease
06/17/2010US20100150867 Use of alpha-glucosidase inhibitors to treat alphavirus infections
06/17/2010US20100150866 Hepatitis C Virus Inhibitors
06/17/2010US20100150863 Hydroxy methyl phenyl pyrazolyl urea compound useful in treatment of cancer
06/17/2010US20100150861 Compostions with enhanced bioavailability and fast acting inhibitor or gastric acid secretion
06/17/2010US20100150844 Use of 8-quinolinol and its analogs to target cancer stem cells
06/17/2010US20100150841 Use of Tumor Necrosis Factor-Alpha P75 Receptor for the Reduction of Inflammation
06/17/2010US20100150840 Small-molecule agonists for type-2 orexin receptor
06/17/2010US20100150839 Compositions and Methods for Modulating Cognitive Function
06/17/2010US20100150838 Methods for evaluating osteoarthritis risk
06/17/2010US20100150836 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
06/17/2010US20100150833 Compounds and amyloid probes thereof for therapeutic and imaging uses
06/17/2010US20100150831 Modulators of cxcr7
06/17/2010US20100150830 Method of treating cancer
06/17/2010US20100150827 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
06/17/2010DE102008062566A1 Aminosäureester-Prodrugs und ihre Verwendung Amino acid ester prodrugs and their use
06/17/2010CA2748691A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010CA2747279A1 3,4 - substituted piperidine derivatives as renin inhibitors
06/17/2010CA2747235A1 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
06/17/2010CA2747232A1 Compounds for use in the treatment of pain
06/17/2010CA2747185A1 Compounds for treating cancer
06/17/2010CA2746701A1 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010CA2746574A1 Feed for preventing and/or treating diseases caused by clostridium bacterium in livestock, and agent against clostridium
06/17/2010CA2746514A1 Gnaq targeted dsrna compositions and methods for inhibiting expression
06/17/2010CA2746491A1 Contact lens drug delivery device
06/17/2010CA2746479A1 Combination of insulin with triazine derivatives and its use for treating diabetes
06/17/2010CA2746475A1 Antitumor combination combining ave8062 and docetaxel
06/17/2010CA2746457A1 Use of racemates of pinocembrin in preparing medicaments for treating stroke
06/17/2010CA2746433A1 Benzothiazole amides for detection of amyloid beta
06/17/2010CA2746429A1 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010CA2746428A1 Synthesis of morphine-6-glucuronide or one of the derivatives thereof
06/17/2010CA2746427A1 Phenylpyrimidone compounds, the pharmaceutical compositions, preparation methods and uses thereof
06/17/2010CA2746422A1 Kinase inhibitor compounds
06/17/2010CA2746421A1 Antimicrobial molecules for treating multi-drug resistant and extensively drug resistant strains of mycobacterium
06/17/2010CA2746420A1 Nutritional intervention for improving muscular function and strength
06/17/2010CA2746357A1 P38 map kinase inhibitors
06/17/2010CA2746354A1 P38 map kinase inhibitors
06/17/2010CA2746339A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
06/17/2010CA2746273A1 Small molecule immunomodulators for alzheimer's disease
06/17/2010CA2746264A1 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
06/17/2010CA2746258A1 Deuterated compounds as hepatitis c virus (hcv) inhibitors
06/17/2010CA2746251A1 Composition comprising isoflavones
06/17/2010CA2746155A1 Oral composition
06/17/2010CA2746129A1 Combinations and modes of administration of therapeutic agents and combination therapy
06/17/2010CA2746070A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
06/17/2010CA2746058A1 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt
06/17/2010CA2746023A1 Imidazopyrazine syk inhibitors
06/17/2010CA2745980A1 Rifaximin complexes
06/17/2010CA2745970A1 Dihydropyrimidopyrimidine derivative
06/17/2010CA2745969A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010CA2745959A1 Dihydropyrimidopyrimidine derivatives
06/17/2010CA2745934A1 Sustained release systems of ascorbic acid phosphate
06/17/2010CA2745922A1 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
06/17/2010CA2745871A1 Imidazopyrazine syk inhibitors
06/17/2010CA2745854A1 Tetrahydrotriazine compounds for treating diseases associated with ampk activity
06/17/2010CA2745849A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
06/17/2010CA2745843A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/17/2010CA2745725A1 2- (piperidin-1-yl) -4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections
06/17/2010CA2745541A1 A method for contraception
06/17/2010CA2745537A1 Dihydroetorphines and their preparation
06/17/2010CA2745523A1 Uracyl cyclopropyl nucleotides
06/17/2010CA2745203A1 3,6-disubstituted xanthylium salts
06/17/2010CA2745084A1 Ulipristal acetate tablets
06/17/2010CA2745063A1 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
06/17/2010CA2745052A1 Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines
06/17/2010CA2744563A1 Azaindole derivatives as kinase inhibitors
06/17/2010CA2744498A1 Mlk inhibitors and methods of use
06/17/2010CA2744456A1 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
06/17/2010CA2744367A1 Combined drug administration
06/17/2010CA2744124A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/17/2010CA2743768A1 Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease
06/17/2010CA2743557A1 Spiro azepane-oxazolidinones as kv1.3 potassium channel blockers
06/17/2010CA2742920A1 New inhibitors for treating diseases associated with an excess transport of hyaluronan
06/17/2010CA2742905A1 Compounds having activity in correcting mutant cftr cellular processing
06/17/2010CA2742711A1 Polymorph ii of an antifungal compound
06/17/2010CA2734283A1 Inhalant formulations comprising a bisphosphonate and a pyrazolone derivative and methods for using the same
06/17/2010CA2729684A1 Compositions and methods for promoting vascular barrier function and treating pulmonary fibrosis
06/16/2010EP2196930A1 Cavity induced allosteric modificatin of intermolecular interactions and methods of identifiying compounds that effect the same
06/16/2010EP2196472A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
06/16/2010EP2196469A1 Conjugates with anti-inflammatory activity
06/16/2010EP2196466A1 Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or heamatological diseases or conditions
06/16/2010EP2196465A1 (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
06/16/2010EP2196463A1 Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
06/16/2010EP2196460A1 Sulfonic acid salt compound of 4-carbamoyl-5-hydroxy-imidazole derivative
06/16/2010EP2196459A1 5-membered heterocyclic compound
06/16/2010EP2196453A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents
06/16/2010EP2196226A2 Coated medical devices
06/16/2010EP2196218A2 Use of anti-TNFalpha antibodies and another drug
06/16/2010EP2196217A1 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
06/16/2010EP2196208A1 Plant extract and use thereof
06/16/2010EP2196207A2 Method for the purification of carotenoids from plant extracts and the products so obtained
06/16/2010EP2196206A1 Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient
06/16/2010EP2196205A1 Topoisomerase poisons
06/16/2010EP2196204A1 Myrothecium sp. mycelial extract for inhibiting tumor cells growth
06/16/2010EP2196203A2 Use of amino-acid based compositions for the treatment of sarcopenia
06/16/2010EP2196202A1 Inflammation-inhibiting compounds Lys-Pro-Thr and Lys-Pro
06/16/2010EP2196201A2 Combination of an alpha-2-delta ligand with a pdev inhibitor or a muscarinic antagonist to treat lower urinary tract symptoms
06/16/2010EP2196200A1 Cyclohexenone derivative for treating or preventing hypesthesia or hyperesthesia caused by diabetes
1 ... 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 ... 7860